Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled dry powder mannitol in cystic fibrosis
NCT00455130Phase 2Completed
- Sponsor
- Syntara Limited
- Start
- Mar 2004
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of Bronchitol in cystic fibrosis (CF) (2 arms), sponsored by Syntara Limited. Primary endpoint: Forced Expiratory Volume in 1 second at 2 weeks. Started Mar 2004; status: completed.
02
Drugs
Bronchitol
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00455130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00455130.